Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Apr;9(4):812-4.
doi: 10.2215/CJN.12601213. Epub 2014 Jan 23.

Dialysis therapies: a National Dialogue

Rajnish Mehrotra  1 , Anil Agarwal, Joanne M Bargman, Jonathan Himmelfarb, Kirsten L Johansen, Suzanne Watnick, Jack Work, Kevin McBryde, Michael Flessner, Paul L Kimmel; Kidney Research National Dialogue (KRND)
Affiliations

Dialysis therapies: a National Dialogue

Rajnish Mehrotra et al. Clin J Am Soc Nephrol. 2014 Apr.

Abstract

The National Institute of Diabetes, Digestive, and Kidney Diseases-supported Kidney Research National Dialogue asked the scientific community to formulate and prioritize research objectives that would improve our understanding of kidney function and disease. Kidney Research National Dialogue participants identified the need to improve outcomes in ESRD by decreasing mortality and morbidity and enhancing quality of life as high priority areas in kidney research. To reach these goals, we must identify retained toxins in kidney disease, accelerate technologic advances in dialysate composition and devices to remove these toxins, advance vascular access, and identify measures that decrease the burden of disease in maintenance dialysis patients. Together, these research objectives provide a path forward for improving patient-centered outcomes in ESRD.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Focusing research on distinct priorities, including ameliorating disease risk, improving hemodialysis vascular access and peritoneal dialysis catheter design and nutritional outcomes, identifying uremic toxins, and improving dialysis therapies, will result in improvement of patient-centered outcomes, such as enhancing quality and quantity of life for ESRD patients treated with dialysis.
See this image and copyright information in PMC

References

    1. United States Renal Data System : US Department of Public Health and Human Services, Public Health Service, Bethesda, MD, National Institutes of Health, 2012
    1. Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E: Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 171: 110–118, 2011 - PubMed
    1. Parker TF, 3rd, Straube BM, Nissenson A, Hakim RM, Steinman TI, Glassock RJ: Dialysis at a crossroads—Part II: A call for action. Clin J Am Soc Nephrol 7: 1026–1032, 2012 - PubMed